Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Public ClinicalTrials.gov record NCT04501666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective was to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (\>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.
Study identification
- NCT ID
- NCT04501666
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 286 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2020 (Actual)
- Primary completion
- Nov 11, 2022 (Actual)
- Completion
- Feb 21, 2023 (Actual)
- Last update posted
- Jul 10, 2024
2020 – 2023
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site | Birmingham | Alabama | 35233 | — |
| Galderma Investigational Site | Birmingham | Alabama | 35244 | — |
| Galderma Investigational Site | Los Angeles | California | 90045 | — |
| Galderma Investigational Site | Sacramento | California | 95815 | — |
| Galderma Investigational Site | San Diego | California | 92121 | — |
| Galderma Investigational Site | San Diego | California | 92130 | — |
| Galderma Investigational Site | Santa Monica | California | 94404 | — |
| Galderma Investigational Site | Delray Beach | Florida | 33484 | — |
| Galderma Investigational Site | Hollywood | Florida | 33021 | — |
| Galderma Investigational Site | Largo | Florida | 33770 | — |
| Galderma Investigational Site | Miami | Florida | 33125 | — |
| Galderma Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Galderma Investigational Site | Tampa | Florida | 33607 | — |
| Galderma Investigational Site | Columbus | Georgia | 31904 | — |
| Galderma Investigational Site | Macon | Georgia | 31217 | — |
| Galderma Investigational Site | Chicago | Illinois | 60613 | — |
| Galderma Investigational Site | Lake Bluff | Illinois | 60044 | — |
| Galderma Investigational Site | Topeka | Kansas | 66614 | — |
| Galderma Investigational Site | Baltimore | Maryland | 21231 | — |
| Galderma Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Galderma Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Galderma Investigational Site | St Louis | Missouri | 63110 | — |
| Galderma Investigational Site | New York | New York | 10065 | — |
| Galderma Investigational Site | High Point | North Carolina | 27262 | — |
| Galderma Investigational Site | Raleigh | North Carolina | 27617 | — |
| Galderma Investigational Site | Cleveland | Ohio | 44106 | — |
| Galderma Investigational Site | Norman | Oklahoma | 73071 | — |
| Galderma Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Galderma Investigational Site | Johnston | Rhode Island | 02919 | — |
| Galderma Investigational Site | Providence | Rhode Island | 02903 | — |
| Galderma Investigational Site | Knoxville | Tennessee | 37909 | — |
| Galderma Investigational Site | Austin | Texas | 78738 | — |
| Galderma Investigational Site | Bellaire | Texas | 77401 | — |
| Galderma Investigational Site | Laredo | Texas | 78401 | — |
| Galderma Investigational Site | Salt Lake City | Utah | 84117 | — |
| Galderma Investigational Site | Springville | Utah | 84663 | — |
| Galderma Investigational Site | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04501666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04501666 live on ClinicalTrials.gov.